Contextual Main Account Blog

Pros and Cons of Liquid Biopsy for Cancer Management

Introduction In the last decade many new targeted therapies have been approved by the FDA. The National Comprehensive Cancer Network (NCCN) guidelines now recommend matching genomic markers to targeted therapies as a first-line strategy for the following cancers: Non-small cell lung cancer Chronic myelogenous leukemia Metastatic melanoma Breast Gastric Gastrointestinal stromal tumor Hepatocellular carcinoma Colorectal While many patients now have …